+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase Not Applicable
Age: 22Years - 80Years
All Genders
ID07821957

Evaluation of a New Flow Diverter Stent for Treating Intracranial Wide-Neck Aneurysms in China A Multicenter Prospective Study by Beijing Tiantan Hospital

Led by Beijing Tiantan Hospital · Updated on 2026-09-16

280

Participants Needed

1

Research Sites

17 weeks

Total Duration

AI-Summary

What This Trial Is About

Intracranial aneurysm is a common cerebrovascular condition that can be treated with various methods, including surgery and endovascular approaches. Among these, flow diverters have gained attention for their unique way of redirecting blood flow to encourage clot formation within the aneurysm, aiming to treat it effectively. Devices like the Pipeline flow diverter have shown safety and effectiveness and are becoming preferred options for managing intracranial aneurysms. This study evaluates a new generation of flow diverter stents such as Pipeline Shield and Lattice for treating intracranial wide-neck aneurysms in China. Patients will receive implantation of these devices according to their instructions for use and local medical practices. Alongside the stent, participants will take dual antiplatelet therapy for at least 3 to 6 months after the procedure. This is a prospective, multicenter, single-group study involving about 280 patients across 15 sites. Participants will be followed up with clinical evaluations and imaging tests like DSA or CTA at 30 days, 6 months, 1 year, and annually up to 4 years after the procedure. The main outcome measured is the rate of complete aneurysm occlusion one year after treatment. Safety and effectiveness will be monitored throughout, including assessments of neurological function using the Modified Rankin Scale. The total study duration extends until the end of 2030.

CONDITIONS

Brief Title

A Multicenter Prospective Study of New Flow Diverter Stent on the Treatment of Intracranial Aneurysms in China

Research Team

H

Hengwei Jin

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here